Quantum BioPharma is trading 5.15% higher at $4.08, with the move appearing primarily sector-driven as biotech ETF XBI rises pre-market.
- Shares are up from the September 23 close of $3.88.
- No new company-specific announcement was identified for September 24; recent FDA trial clearance and analyst coverage are earlier developments.
- XBI is up 2.61% pre-market despite weaker major-index futures.